{"schema_version":"secwatch.filing_event.v1","accession":"0001737287-24-000062","form_type":"8-K","ticker":"ALLO","cik":"0001737287","company_name":"Allogene Therapeutics, Inc.","filed_at":"2024-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.408783+00:00","generated_at":"2026-05-30T19:22:15.087980+00:00","sec_items":["5.05","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Allogene Therapeutics amends Code of Business Conduct and Ethics","bullets":["Updates insider trading policy, antitrust restrictions, and conflicts-of-interest procedures.","Expands fair dealing obligations, gift/entertainment restrictions, and data privacy/cybersecurity requirements.","Adds express requirement to comply with all other Company policies supporting the Code.","Applies to all directors, officers, employees, and certain consultants/contractors."],"urls":{"canonical":"https://secwatch.observer/filing/0001737287-24-000062","json":"https://secwatch.observer/filing/0001737287-24-000062.json","markdown":"https://secwatch.observer/filing/0001737287-24-000062.md","text":"https://secwatch.observer/filing/0001737287-24-000062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737287/000173728724000062/0001737287-24-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737287/000173728724000062/allo-20241003.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T19:22:15.087980+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}